To investigate the inhibitory effect of anthricin on breast cancer cell growth, we first determined cell viability in 2 breast cancer cell lines: MCF7 (estrogen receptor positive) and MDA-MB-231 (estrogen receptor, progesterone receptor, and Her2/Neu receptor negative). Here, PGR is linked to breast cancer.